Latest market price
3.80
-0.17-4.28%
OverviewShort InterestFilings
ACRSQT31Aclaris Therapeutics, Inc.·NASDAQ
3.80-4.28%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 27, 2026424B5Prospectus
Oct 27, 20268-KCurrent report
Oct 27, 20268-KCurrent report
Sep 21, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 06, 2026S-3ASRS-3ASR
Aug 06, 20268-KCurrent report
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Aug 04, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 08, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
May 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
May 05, 20264Statement of changes in beneficial ownership
Apr 28, 20268-KCurrent report
Apr 27, 20264Statement of changes in beneficial ownership
Apr 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 23, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 359
Page
▼
/ 15